載入...
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
BACKGROUND: In 2016, the World Health Organization reclassified the definition of glioblastoma (GBM), dividing these tumors into isocitrate dehydrogenase (IDH)-wild-type and IDH-mutant GBM, where the vast majority of GBMs are IDH-wild-type. Nomograms are useful tools for individualized estimation of...
Na minha lista:
| 發表在: | Neurooncol Adv |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6777501/ https://ncbi.nlm.nih.gov/pubmed/31608326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz007 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|